Tarcha, Eric J.
Kineta (United States)
2 papers on CoChat
Most cited papers
- Verified
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
Tarcha, E. J., Olsen, C. M., Probst, P., Peckham, D., Muñoz-Elías, E. J., Kruger, J. G., & Iadonato, S. P. (2017) · PLOS ONE
Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases
Cited by 167
- Verified
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
Tarcha, E. J., Chi, V., Muñoz-Elías, E. J., Bailey, D., Londono, L. M., Upadhyay, S. K., Norton, K., Banks, A., Tjong, I., Nguyen, H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics
Ion channel regulation and functionT-cell and B-cell Immunology
Cited by 117
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free